These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25611047)

  • 21. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.
    Serra M; Pasello M; Manara MC; Scotlandi K; Ferrari S; Bertoni F; Mercuri M; Alvegard TA; Picci P; Bacci G; Smeland S
    Int J Oncol; 2006 Dec; 29(6):1459-68. PubMed ID: 17088985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.
    Damron TA; Ward WG; Stewart A
    Clin Orthop Relat Res; 2007 Jun; 459():40-7. PubMed ID: 17414166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
    Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
    Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
    Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
    Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.
    G Salazar E; Bernhardt MB; Li Y; Aplenc R; Adamson PC
    Pediatr Blood Cancer; 2015 Jun; 62(6):940-4. PubMed ID: 25704486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of comprehensive thoracic oncology database--tool for translational research.
    Surati M; Robinson M; Nandi S; Faoro L; Demchuk C; Kanteti R; Ferguson B; Gangadhar T; Hensing T; Hasina R; Husain A; Ferguson M; Karrison T; Salgia R
    J Vis Exp; 2011 Jan; (47):. PubMed ID: 21304468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
    Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
    Hawkins DS; Arndt CA
    Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
    Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
    Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
    Iwamoto Y; Tanaka K
    Jpn J Clin Oncol; 2012 Jun; 42(6):467-70. PubMed ID: 22628611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans.
    Pappo AS; Krailo M; Chen Z; Rodriguez-Galindo C; Reaman G
    J Clin Oncol; 2010 Nov; 28(33):5011-6. PubMed ID: 20956621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of archived specimens in evaluation of prognostic and predictive biomarkers.
    Simon RM; Paik S; Hayes DF
    J Natl Cancer Inst; 2009 Nov; 101(21):1446-52. PubMed ID: 19815849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report.
    Kager L; Whelan J; Dirksen U; Hassan B; Anninga J; Bennister L; Bovée JVMG; Brennan B; Broto JM; Brugières L; Cleton-Jansen AM; Copland C; Dutour A; Fagioli F; Ferrari S; Fiocco M; Fleuren E; Gaspar N; Gelderblom H; Gerrand C; Gerß J; Gonzato O; van der Graaf W; Hecker-Nolting S; Herrero-Martín D; Klco-Brosius S; Kovar H; Ladenstein R; Lancia C; LeDeley MC; McCabe MG; Metzler M; Myklebost O; Nathrath M; Picci P; Potratz J; Redini F; Richter GHS; Reinke D; Rutkowski P; Scotlandi K; Strauss S; Thomas D; Tirado OM; Tirode F; Vassal G; Bielack SS
    Clin Sarcoma Res; 2016; 6():3. PubMed ID: 27315524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma.
    Somarelli JA; Rupprecht G; Altunel E; Flamant EM; Rao S; Sivaraj D; Lazarides AL; Hoskinson SM; Sheth MU; Cheng S; Kim SY; Ware KE; Agarwal A; Cullen MM; Selmic LE; Everitt JI; McCall SJ; Eward C; Eward WC; Hsu DS
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue banking for research: connecting the disconnected.
    Thomas G
    Cell Tissue Bank; 2011 Feb; 12(1):29-30. PubMed ID: 20824350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.